Karnalyte Resources Inc. Executive Change

Karnalyte Resources Inc. Executive Change

Canada NewsWire

SASKATOON, June 28, 2017 /CNW/ – Karnalyte Resources Inc. (“Karnalyte” or the “Company“) (TSX: KRN) announced today that effective immediately, Mr. Robin Phinney, President, is no longer with the Company. The Company will make an announcement on plans to replace Mr. Phinney as soon as such information is available.

SOURCE Karnalyte Resources Inc.

View original content: http://www.newswire.ca/en/releases/archive/June2017/29/c4341.html

New Editions of Newsletters from Rigaku Feature Latest Materials Science and Life Science News

The Woodlands, Texas (PRWEB) June 28, 2017

The June editions of The Bridge, the materials science newsletter from Rigaku Corporation, and the Crystallography Times single crystal X-ray diffraction newsletter, are now available to view on the company’s global website.

The Bridge is the materials analysis newsletter from Rigaku, featuring news and analysis methods covering the latest developments in X-ray based materials science. This month's issue contains a Rigaku Journal article describing the principles and applications of multi-layer mirror optics for X-ray diffraction (XRD) measurements as used in the Rigaku SmartLab X-ray diffraction system.

Additional articles, application notes and scientific papers regarding X-ray diffraction, wavelength dispersive X-ray fluorescence (WDXRF), energy dispersive X-ray fluorescence (EDXRF) and Raman spectrometry are also offered, including an application note for XRD users describing quantitative analysis of a non-crystalline (amorphous) phase.

Crystallography Times is a monthly electronic newsletter presented by Rigaku Oxford Diffraction that concentrates on single crystal X-ray diffraction.

The current issue features a comprehensive collection of the latest developments in life sciences from across the globe and highlights the newest research findings and developments. Numerous links to recent crystallographic papers are also provided.

The Product Spotlight in the current issue features Rigaku ChrisAlisPro, the user-inspired data collection and data processing software from Rigaku Oxford Diffraction, designed for small molecule and protein crystallography.

The book review for June 2017 features Not a Scientist – How Politicians Mistake, Misrepresent, and Utterly Mangle Science by Dave Levitan. The book is a revealing examination of the political tricks that subvert scientific progress.

Readers can subscribe to the newsletters or view the current issues online at

https://www.rigaku.com/subscribe

About Rigaku

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, diffraction, and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,400 people in the manufacturing and support of its analytical equipment, which is used in more than 90 countries around the world supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.

For further information, contact:

Michael Nelson

Global Marketing Coordinator

Rigaku Corporation

michael.nelson(at)rigaku(dot)com

Read the full story at http://www.prweb.com/releases/2017/06/prweb14471418.htm

Dow and DuPont Provide Update on Merger

Dow and DuPont Provide Update on Merger

PR Newswire

MIDLAND, Mich. and WILMINGTON, Del., June 28, 2017 /PRNewswire/ – The Dow Chemical Company (NYSE: DOW) and DuPont (NYSE: DD) today jointly provided an update on the status of the anticipated merger of the two companies.

The Boards of Directors of both companies reiterate their support of the merger agreement. In addition, as announced, both Boards support a comprehensive portfolio review for DowDuPont, which is intended to assess current business facts and leverage the knowledge gained over the past year and a half to capture any material value-enhancing opportunities in preparation for the intended creation of three industry-leading companies. 

The Boards have jointly commenced the review and have engaged McKinsey & Co. to assist the companies in this assessment. The lead independent directors of each company are working together to oversee the process. The DowDuPont Board is expected to review the results soon after the merger closes.

“The management teams and directors of both companies are in regular dialogue with our shareholders, and we have undertaken significant preparation work in advance of the close,” said Jeff Fettig, Lead Director of Dow. “As a collective board we are committed to delivering maximum, long-term shareholder value by ensuring that each of the intended companies will have clear focus, an appropriate capital structure, a distinct and compelling investment thesis, scale advantages, and focused investments in innovation to better deliver superior solutions and choices for customers.”

“Dow and DuPont leadership are committed to maximizing the tremendous value creation potential of the merger and anticipated spins,” said Alexander (Sandy) Cutler, Lead Director of DuPont. “Our review will provide an in-depth look at the portfolio mix and alignment across divisions to ensure we capitalize on all value-enhancing opportunities. The output of the review will be an immediate focus for the DowDuPont Board following merger close. If the results of our review demonstrate there is net greater long-term value creation to be realized through a change in the portfolio, it will be pursued.”

The companies reaffirmed their expectation to close the merger in August 2017, with the intended spin-offs to occur within 18 months of closing.

Additional information is available at www.dowdupontunlockingvalue.com.  

ABOUT DOW
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company is driving innovations that extract value from material, polymer, chemical and biological science to help address many of the world’s most challenging problems, such as the need for fresh food, safer and more sustainable transportation, clean water, energy efficiency, more durable infrastructure, and increasing agricultural productivity. Dow’s integrated, market-driven portfolio delivers a broad range of technology-based products and solutions to customers in 175 countries and in high-growth sectors such as packaging, infrastructure, transportation, consumer care, electronics, and agriculture. In 2016, Dow had annual sales of $48 billion and employed approximately 56,000 people worldwide. The Company’s more than 7,000 product families are manufactured at 189 sites in 34 countries across the globe. References to “Dow” or the “Company” mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.

ABOUT DUPONT
DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.

Cautionary Notes on Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. These and other forward-looking statements, including the failure to consummate the proposed transaction or to make or take any filing or other action required to consummate such transaction on a timely matter or at all, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to, (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining regulatory approvals, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the new combined company’s operations and other conditions to the completion of the merger, (ii) the ability of Dow and DuPont to integrate the business successfully and to achieve anticipated synergies, risks and costs and pursuit and/or implementation of the potential separations, including anticipated timing, any changes to the configuration of businesses included in the potential separation if implemented, (iii) the intended separation of the agriculture, material science and specialty products businesses of the combined company post-mergers in one or more tax efficient transactions on anticipated terms and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances, disruptions in the financial markets or other potential barriers, (iv) potential litigation relating to the proposed transaction that could be instituted against Dow, DuPont or their respective directors, (v) the risk that disruptions from the proposed transaction will harm Dow’s or DuPont’s business, including current plans and operations, (vi) the ability of Dow or DuPont to retain and hire key personnel, (vii) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the merger, (viii) uncertainty as to the long-term value of DowDuPont common stock, (ix) continued availability of capital and financing and rating agency actions, (x) legislative, regulatory and economic developments, (xi) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger that could affect Dow’s and/or DuPont’s financial performance, (xii) certain restrictions during the pendency of the merger that may impact Dow’s or DuPont’s ability to pursue certain business opportunities or strategic transactions and (xiii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks, as well as other risks associated with the proposed merger, are more fully discussed in the joint proxy statement/prospectus included in the Registration Statement filed with the SEC in connection with the proposed merger. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Dow’s or DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. Neither Dow nor DuPont assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dow-and-dupont-provide-update-on-merger-300481579.html

SOURCE DuPont